Gauging the Antiobesity Potential of Oral Semaglutide in Type 2 Diabetes in the Indian Context. (2023). Indian Journal Of Clinical Practice, 33(11), 8-12. https://ojs.ijcp.in/index.php/IJCP/article/view/147